These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 645020)

  • 21. [Antidepressive agents in the treatment of obsessive-compulsive disorder].
    Hansen ES; Bolwig TG
    Ugeskr Laeger; 1997 Jan; 159(2):183-4. PubMed ID: 9012092
    [No Abstract]   [Full Text] [Related]  

  • 22. Amitriptyline therapy of obsessive-compulsive neurosis.
    Snyder S
    J Clin Psychiatry; 1980 Aug; 41(8):286-9. PubMed ID: 7400108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical trial of a new drug, analog of chlordiazepoxide, for treatment of anxiety and tension.
    Gilbert MM
    Int J Neuropsychiatry; 1965 Dec; 1(6):556-8. PubMed ID: 5886535
    [No Abstract]   [Full Text] [Related]  

  • 24. Valproate pretreatment for the difficult-to-treat patient with OCD.
    Deltito JA
    J Clin Psychiatry; 1994 Nov; 55(11):500. PubMed ID: 7989288
    [No Abstract]   [Full Text] [Related]  

  • 25. A new antidepressant agent: amitriptyline-N-oxide.
    Borromei A
    Adv Biochem Psychopharmacol; 1982; 32():43-7. PubMed ID: 7046367
    [No Abstract]   [Full Text] [Related]  

  • 26. Psychopharmacologic treatment of obsessive-compulsive disorder.
    Thorneloe WF
    J Med Assoc Ga; 1988 Nov; 77(11):825-6. PubMed ID: 3057098
    [No Abstract]   [Full Text] [Related]  

  • 27. [A serotoninergic antidepressive, indalpine].
    Rigal J
    Ann Med Psychol (Paris); 1985 Jul; 143(7):664-76. PubMed ID: 3938629
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of endogenous depression with psychopharmaceutics].
    Grützner A
    Med Klin; 1967 Feb; 62(7):241-5. PubMed ID: 4875545
    [No Abstract]   [Full Text] [Related]  

  • 29. Disabling obsessive thoughts responsive to antidepressants.
    Jenike MA; Armentano ME; Baer L
    J Clin Psychopharmacol; 1987 Feb; 7(1):33-5. PubMed ID: 3818991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Obsessive-compulsive symptoms associated with panic disorder. Predictive factor of a good therapeutic response to fluvoxamine].
    Servant D; Bailly D; Le Seac'h H; Parquet PJ
    Encephale; 1990; 16 Spec No():359-62. PubMed ID: 2120029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary MHPG is not a good predictor of antidepressive drug response.
    Puzyński S; Rode A; Bidziński A; Mrozek S; Załuska M
    Pol J Pharmacol Pharm; 1984; 36(4):329-35. PubMed ID: 6527968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Further observations on the effects of the treatment with amitriptyline and perphenazine in essential headache].
    Pisani RA; Lazzari R; Franzese A; Arzilli A
    Clin Ter; 1987 Sep; 122(5):345-50. PubMed ID: 2972451
    [No Abstract]   [Full Text] [Related]  

  • 33. Antiobsessional and antidepressant effects of clomipramine in the treatment of obsessive-compulsive disorder.
    Insel TR; Alterman I; Murphy DL
    Psychopharmacol Bull; 1982 Oct; 18(4):115-7. PubMed ID: 7156271
    [No Abstract]   [Full Text] [Related]  

  • 34. [Drug treatment of compulsive disorder].
    Rapoport JL
    Nervenarzt; 1991 May; 62(5):318-20. PubMed ID: 1865964
    [No Abstract]   [Full Text] [Related]  

  • 35. [The role of drug therapy in the treatment of obsessive-compulsive disorders].
    Teeuwisse JM; Nolen WA
    Ned Tijdschr Geneeskd; 1989 Dec; 133(52):2605-8. PubMed ID: 2575230
    [No Abstract]   [Full Text] [Related]  

  • 36. [Efficacy assessment of fluoxetine treatment of outpatients with obsessive-compulsive disorder: a preliminary report].
    Wandzel L
    Psychiatr Pol; 1997; 31(4):429-35. PubMed ID: 9527686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imipramine and placebo in the treatment of obsessive-compulsives: their effect on depression and on obsessional symptoms.
    Foa EB; Steketee G; Kozak MJ; Dugger D
    Psychopharmacol Bull; 1987; 23(1):8-11. PubMed ID: 3602334
    [No Abstract]   [Full Text] [Related]  

  • 38. Management of obsessive-compulsive disorder.
    Veale D
    Br J Hosp Med; 1990 Apr; 43(4):278-81. PubMed ID: 2189520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obsessive compulsive disorder, depression, and fluoxetine.
    Hollander E; Mullen L; DeCaria CM; Skodol A; Schneier FR; Liebowitz MR; Klein DF
    J Clin Psychiatry; 1991 Oct; 52(10):418-22. PubMed ID: 1938978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Inadequate pharmacotherapy in patients with obsessive-compulsive disorder].
    Denys D; van Megen HJ; Westenberg HG
    Ned Tijdschr Geneeskd; 2001 May; 145(19):914-8. PubMed ID: 11387867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.